Xeris Biopharma Reports Strong Financial Results for Fiscal Year 2024
Xeris Biopharma announced a total revenue of $163.9 million for the fiscal year ending on March 6, 2024. The company ...
© 2024 Stocks Today
Tag: XERS
Xeris Biopharma Holdings Reports Strong Fourth Quarter Financial Results
Xeris Biopharma Holdings (NASDAQ:XERS) announced their fourth-quarter financial results on March 6, 2024. The company reported a GAAP EPS of ...
Title Xeris Biopharma Holdings Inc Completes Financial Restructuring with Hayfin Capital Management LLP
Xeris Biopharma Holdings, Inc. has recently completed a significant financial restructuring on March 6, 2024. The company successfully refinanced its ...
Popular News
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Unlocking the Future: The Rise of Open-Source FPGA Development Tools
-
The Future of Secure Communications: How Quantum-Resistant Encryption is Revolutionizing Wireless Technology
-
The Booming Market of Plant-Based Pharmaceuticals for Neurological Conditions
-
Unlocking Potential: How Recent Acquisitions in the Battery Technology Sector Are Reshaping the Energy Landscape